ARCHIVES

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR

May 6, 1994

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

June 10, 1988

NCI To Recomplete Frederick Contract To Start In 1977

October 17, 1975

RG7204 Meets Endpoints Of Extending Survival, PFS

February 25, 2011

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995

NCCN Updates Myeloma Clinical Practice Guidelines

September 26, 2003